Shanghai OrigiMed Medical Technology Co., Ltd.   Report issue

For profit Phase 2
Founded: Shanghai China (2016)
Status: No NME R&D (2016)

Organization Overview

First Clinical Trial
2018
NCT03796429
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Shanghai OrigiMed Medical Technology Co., Ltd.